DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its first quarter 2022 financial results on Wednesday, May 11, 2022, at
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust will participate in the following investor conferences in the month of May: Bloom Burton & Co….
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its first quarter 2022 financial results on Wednesday, May 11, 2022, at
DRI Healthcare Trust Announces Upsized Credit Facility
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into an amended and restated credit agreement (the “Amended…
DRI Healthcare Trust Announces Upsized Credit Facility
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into an amended and restated credit agreement (the “Amended…
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results
– Announced growth-oriented and accretive transactions of up to $186 million – – Continued strong performance of existing assets and financial results – – Acquired over one million units under…
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results
– Announced growth-oriented and accretive transactions of up to $186 million – – Continued strong performance of existing assets and financial results – – Acquired over one million units under…
DRI Healthcare Trust Comments on FDA Approval of VONJOTM (pacritinib)
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI”) today announced that it has been notified by CTI BioPharma Corp. (“CTI”) that the U.S. Food and Drug Administration (“FDA”) has approved…
DRI Healthcare Trust Comments on FDA Approval of VONJOTM (pacritinib)
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI”) today announced that it has been notified by CTI BioPharma Corp. (“CTI”) that the U.S. Food and Drug Administration (“FDA”) has approved…
DRI Healthcare Trust to Host Fourth Quarter Earnings Call and Webcast on March 8, 2022
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its fourth quarter and full-year 2021 financial results on Tuesday,…